Lucky 7
liked
Lucky 7
liked
$UBS Group (UBS.US)$ named chipmaker $NVIDIA (NVDA.US)$ a "top pick," citing its "wide moats" in the sector. Plus, the company is enjoying tailwinds from $Micron Technology (MU.US)$ upbeat quarterly report, with officials noting they expect the chip shortage to ease over the coming year.
Analyst Timothy Arcuri believes that Nvidia will likely benefit from building more "stable" revenue sources around its GPU and software moats. At the same time, $Marvell Technology (MRVL.US)$ can use its "broad portfolio" and 5-nanometer investments in a host of new applications and opportunities. UBS has a buy rating on Nvidia.
Nvidia is the top designer of discrete graphics processing units that enhance the experience on computing platforms.
Nvidia's chips serve a variety of end markets, including high-end PCs for gaming, data centers, and automotive infotainment systems.
Nvidia has broadened its focus from traditional PC graphics applications such as gaming to more complex and favorable opportunities, including artificial intelligence and autonomous driving, which leverage the high-performance capabilities of the firm's graphics processing units.
Price Action: NVDA shares traded higher by 4.37% at $289.38 on the last check Tuesday.
Analyst Timothy Arcuri believes that Nvidia will likely benefit from building more "stable" revenue sources around its GPU and software moats. At the same time, $Marvell Technology (MRVL.US)$ can use its "broad portfolio" and 5-nanometer investments in a host of new applications and opportunities. UBS has a buy rating on Nvidia.
Nvidia is the top designer of discrete graphics processing units that enhance the experience on computing platforms.
Nvidia's chips serve a variety of end markets, including high-end PCs for gaming, data centers, and automotive infotainment systems.
Nvidia has broadened its focus from traditional PC graphics applications such as gaming to more complex and favorable opportunities, including artificial intelligence and autonomous driving, which leverage the high-performance capabilities of the firm's graphics processing units.
Price Action: NVDA shares traded higher by 4.37% at $289.38 on the last check Tuesday.
15
2
Lucky 7
voted
moomoo annual ceremony is happening right now!
Check it out here:
2021 in Review: Grow Together to the Moon!
When can I get the vaccine? One of the most-searched questions on Google indicates people's biggest worry in 2021. However, it's an entirely different story for vaccine stocks holders. Sometimes they want the market sentiments to be different because they found that the line in the cases-versus-price graph increases exponentially.
Instead of getting vaccinated, investors stared at news channels. They tried to find the next catalyst for a strong momentum of growth. Are they speculating? Yes, they are. Maybe you'd like to join them if you look at the cost-benefit ratio or the daily performance of the trending vaccine stocks.
Anyway, I sincerely hope that the vaccines will be enough for every mooer. Sufficient supply also indicates healthy cash flows... Oh, I mean, the virus might stop spreading if most of us are vaccinated.
We also hope that the vaccine stocks could become value stocks with solid business models and stable cash flows one day. In that case, there will be no need for us to be on tenterhooks all day, waiting for monthly job reports or the infection numbers anymore.
Well, unless you enjoy the extreme volatility of the sudden outbreaks and are confident that you can profit from the biotech stocks shortly.
Did you get the vaccine?
Do you think the word "Vaccine" here qualifies to be the word of the year?
If you've got better ideas, please comment below to let us know.
You May Also Like:
Word of the Year: Apes
Word of the Year: Musk
Check it out here:
2021 in Review: Grow Together to the Moon!
When can I get the vaccine? One of the most-searched questions on Google indicates people's biggest worry in 2021. However, it's an entirely different story for vaccine stocks holders. Sometimes they want the market sentiments to be different because they found that the line in the cases-versus-price graph increases exponentially.
Instead of getting vaccinated, investors stared at news channels. They tried to find the next catalyst for a strong momentum of growth. Are they speculating? Yes, they are. Maybe you'd like to join them if you look at the cost-benefit ratio or the daily performance of the trending vaccine stocks.
Anyway, I sincerely hope that the vaccines will be enough for every mooer. Sufficient supply also indicates healthy cash flows... Oh, I mean, the virus might stop spreading if most of us are vaccinated.
We also hope that the vaccine stocks could become value stocks with solid business models and stable cash flows one day. In that case, there will be no need for us to be on tenterhooks all day, waiting for monthly job reports or the infection numbers anymore.
Well, unless you enjoy the extreme volatility of the sudden outbreaks and are confident that you can profit from the biotech stocks shortly.
Did you get the vaccine?
Do you think the word "Vaccine" here qualifies to be the word of the year?
If you've got better ideas, please comment below to let us know.
You May Also Like:
Word of the Year: Apes
Word of the Year: Musk
140
15
Lucky 7
voted
If the seven days Santa Claus Rally is real, then remember to get in on the 1st day and exit before the 7th day to give your portfolio a boost!
Top 18 Actives (20 Dec 2021)
$Apple (AAPL.US)$
$AT&T (T.US)$
$Ford Motor (F.US)$
$AMC Entertainment (AMC.US)$
$Carnival (CCL.US)$
$Bank Bradesco SA(prefer share ADS) (BBD.US)$
$Bank of America (BAC.US)$
$Pfizer (PFE.US)$
$NIO Inc (NIO.US)$
$American Airlines (AAL.US)$
$NVIDIA (NVDA.US)$
$Palantir (PLTR.US)$
$Cerner (CERN.US)$
$Lucid Group (LCID.US)$
$Advanced Micro Devices (AMD.US)$
$Itau Unibanco (ITUB.US)$
$Annaly Capital Management Inc (NLY.US)$
$Citigroup (C.US)$
Top 18 Actives (20 Dec 2021)
$Apple (AAPL.US)$
$AT&T (T.US)$
$Ford Motor (F.US)$
$AMC Entertainment (AMC.US)$
$Carnival (CCL.US)$
$Bank Bradesco SA(prefer share ADS) (BBD.US)$
$Bank of America (BAC.US)$
$Pfizer (PFE.US)$
$NIO Inc (NIO.US)$
$American Airlines (AAL.US)$
$NVIDIA (NVDA.US)$
$Palantir (PLTR.US)$
$Cerner (CERN.US)$
$Lucid Group (LCID.US)$
$Advanced Micro Devices (AMD.US)$
$Itau Unibanco (ITUB.US)$
$Annaly Capital Management Inc (NLY.US)$
$Citigroup (C.US)$
38
7
Lucky 7
liked
The major averages fell on Monday as investors grappled with the resurgence of Covid cases spurred from the newfound omicron variant.
The $Dow Jones Industrial Average (.DJI.US)$ dropped 433.28 points to 34,932.16. The $S&P 500 Index (.SPX.US)$ dipped 1.1% to 4,568.02 and the technology-focused $Nasdaq Composite Index (.IXIC.US)$ declined 1.2% to 14,980.94. The small-cap benchmark $iShares Russell 2000 ETF (IWM.US)$ lost nearly 1.6%.
The S&P 500 fell 3.01% over the past three days, as of Dec. 20, making it the worst decline over a three-day span since September. The Nasdaq Composite has also tumbled 3.76% over the past three days, marking the worst three-day stretch since May.
$Carnival (CCL.US)$ $Pfizer (PFE.US)$ $American Airlines (AAL.US)$ $DaVita (DVA.US)$ $Dish Network (DISH.US)$
The $Dow Jones Industrial Average (.DJI.US)$ dropped 433.28 points to 34,932.16. The $S&P 500 Index (.SPX.US)$ dipped 1.1% to 4,568.02 and the technology-focused $Nasdaq Composite Index (.IXIC.US)$ declined 1.2% to 14,980.94. The small-cap benchmark $iShares Russell 2000 ETF (IWM.US)$ lost nearly 1.6%.
The S&P 500 fell 3.01% over the past three days, as of Dec. 20, making it the worst decline over a three-day span since September. The Nasdaq Composite has also tumbled 3.76% over the past three days, marking the worst three-day stretch since May.
$Carnival (CCL.US)$ $Pfizer (PFE.US)$ $American Airlines (AAL.US)$ $DaVita (DVA.US)$ $Dish Network (DISH.US)$
45
2
Lucky 7
liked
3